Global News 2
COVID-19 Pandemic Threatens HIV Drug Supplies
There is mounting concern in many countries, and emerging acutely in Asia, about a growing shortage of lifesaving antiretroviral drugs as a result of supply chain disruptions and stock-outs caused by the COVID-19 pandemic. Experts fear that further disruptions could halt and even reverse the hard-won progress on HIV/AIDS that has been achieved in many […]
amfAR’s TREAT Asia program contributes to success of multi-year collaboration on treatment access
More than 58 million people worldwide are living with chronic hepatitis C virus (HCV) infection, according to the World Health Organization. In 2019, an estimated 290,000 people died from diseases such as cirrhosis or liver cancer as a consequence of HCV.
Tracking COVID-19’s Impact and Vaccine Uptake in the Asia-Pacific Region
TREAT Asia program launches new website with up-to-date data across graphs, tables, and maps charting the impact of COVID-19 in the region.
TREAT Asia Mourns the Passing of Cambodian Network Investigator Dr. Ly Penh Sun
With the passing of Dr. Ly Penh Sun on November 9, 2021, we lost a regional champion for HIV prevention, care, and research.
New Pediatric HIV Site in Indonesia Joins TREAT Asia Research Network
TREAT Asia has added a new site to their pediatric HIV research program with the Kirby Institute, as part of the US NIH-funded International Epidemiology Databases to Evaluate AIDS (IeDEA) Asia-Pacific network.
NIH Award Reaffirms TREAT Asia’s Collaborative Leadership on HIV/AIDS in the Asia-Pacific
For 20 years, amfAR’s TREAT Asia program has been working with partners across the region to expand access to treatment for HIV and related conditions such as hepatitis C and improve standards of care.
A Forgotten Epidemic: Expanding Treatment Access for Hepatitis C
Despite the existence of direct-acting antivirals (DAAs) that can cure more than 95% of people with HCV, these drugs remain difficult to access for those who need them.
A Neglected Population: Transgender Inclusion in National HIV Plans
Worldwide, transgender people are disproportionately impacted by HIV, but historically overlooked in HIV National Strategic Plans (NSPs).
Getting PrEP to Key Populations Is Critical to Global Fight Against HIV
Key populations and their partners account for 50% or more of global HIV infections—80% of new HIV infections outside of sub-Saharan Africa.
ViiV Healthcare and TREAT Asia Partner on Important New Study of Young Adults with HIV
There are more than five million adolescents and young adults living with HIV worldwide, many of whom acquired the virus as infants and must navigate the complex transition from pediatric to adult care. The study of pediatric and adolescent HIV has long been a focus of amfAR’s TREAT Asia program, whose pediatric HIV database, launched […]
From the Front Lines: Malaysia
At the end of December 2019, the world heard about the cases in China, and everyone hoped that it would go no further. Malaysia saw its first case on January 25th, 2020. We went from having 4 beds for COVID-19 patients at the end of February, to 80 beds for patients in 3 weeks.
From the Front Lines: The Philippines
Our institution acts as the referral laboratory for the whole country for the SARS CoV-2 PCR test. But when it comes to patient management, we have a very limited number of beds in our ER and in our ward.
Can Exposure to Different Infections Affect the HIV Reservoir?
mfAR grantee and TREAT Asia Investigator Dr. Reena Rajasuriar is working to shed light on how HIV reservoir size may differ in lower- vs. higher-income countries, which may point to a need for different cure strategies.
Challenges for Young People Around HIV Disclosure
Stigma makes many people living with HIV (PLHIV) want to keep their diagnosis a secret.
amfAR Researchers Unable to Find HIV In London Transplant Patient
A stem cell transplant patient from London has not experienced a rebound of his HIV during the past 18 months off antiretroviral therapy (ART).